Myasthenia Gravis Notes

Myasthenia Gravis (MG)

  • A chronic autoimmune disorder.
  • Antibodies destroy communication between nerves and muscles.
  • Results in weakness of skeletal muscles.

Key Characteristics

  • Affects voluntary muscles, especially those controlling:
    • Eyes
    • Mouth
    • Throat
    • Limbs

Risk Factors

  • Can strike anyone at any age.
  • More frequent in:
    • Young women (ages 20-30)
    • Men aged 50 and older

Cause and Cure

  • Cause is unknown.
  • Not inherited, not contagious.
  • No cure exists.
  • Early detection and management improve the quality and duration of life.

Temporary MG in Fetuses

  • Antibodies can pass from a mother with MG to the fetus.
  • This results in a temporary form of MG.
  • Generally resolves in 2-3 months.

Pathophysiology

  • Typically develops later in life.
  • Antibodies attack normal receptors on muscles.
  • This blocks the chemicals needed to stimulate muscle contraction.

Signs and Symptoms

  • Difficulty swallowing or breathing
  • Visual problems:
    • Drooping eyelids (ptosis)
    • Double vision (diplopia)
  • Muscle weakness and fatigue:
    • Intensity may vary rapidly (over days or hours)
    • Worsens with muscle use (early fatigue)
  • Facial muscle involvement:
    • Mask-like appearance
    • Smile may appear like a snarl
  • Trouble swallowing or pronouncing words
  • Weakness of the neck or limbs

Diagnostic Tests

  1. Response to Medicines:
    • Muscle weakness improves temporarily with anticholinesterase medicine.
    • A positive response confirms MG.
  2. Blood Tests:
    • Looks for specific antibodies associated with MG.
  3. Genetic Tests:
    • Checks for related conditions that run in families.
  4. Nerve Conduction Studies:
    • Repetitive nerve stimulation is used.
  5. Electromyogram (EMG):
    • Measures electrical activity of a muscle.
    • Detects abnormal muscle activity due to neuromuscular conditions.

Treatment Basis

  • Age of the patient
  • Overall health and medical history
  • Severity of the condition
  • Patient's ability to handle treatments
  • Expected duration of the condition
  • Patient preferences

Treatment

  • No cure for MG.
  • Symptoms can be controlled.
  • Lifelong medical condition.
  • Early detection is key to management.

Treatment Goal

  • Increase muscle function.
  • Prevent swallowing and breathing problems.

Nursing Management

  • Improve muscle strength
  • Manage symptoms
  • Prevent complications

Key Areas of Care (Nursing Management)

  • Monitoring:
    • Muscle strength
    • Respiratory function
    • Swallowing ability
  • Nutritional support
  • Education:
    • Medication management
    • Crisis prevention

Assessment and Monitoring (Nursing Management)

  • Muscle Strength:
    • Assess regularly, document changes including onset, duration and frequency of weakness
  • Respiratory Function:
    • Monitor rate, depth, effort, breathing pattern, breath sounds, and oxygen saturation.
    • Report concerning findings (respiratory distress, hypoxemia).
  • Swallowing Ability:
    • Assess ability.
    • Implement aspiration precautions (dysphagia is common).
  • Fatigue:
    • Recognize and address fatigue to prevent exacerbation and crises.

Interventions (Nursing Management)

  • Nutritional Support:
    • Small, frequent meals.
    • Soft foods and high-calorie snacks (to manage dysphagia).
  • Respiratory Support:
    • Ensure access to suctioning and emergency equipment (for potential respiratory failure).
  • Medication Management:
    • Administer prescribed medications (anticholinesterase drugs).
    • Monitor for side effects.
  • Activity Management:
    • Encourage rest to reduce fatigue and prevent crises.
    • Plan short activities during times of maximal muscle strength.
  • Crisis Management:
    • Be prepared to manage myasthenic and cholinergic crises.
    • Recognize signs/symptoms and take appropriate actions.
  • Patient Education:
    • Educate patients/families about MG, its management, medication compliance, potential triggers (infections, stress), and crisis prevention.
  • Support:
    • Offer emotional support to patients and families (chronic condition can be challenging).
  • Eye Care:
    • Artificial tears during the day.
    • Eye patch (to prevent corneal damage if ptosis is present).
  • Thymectomy:
    • If patient underwent thymectomy, be prepared for potential exacerbation of MG symptoms.

Thymus Gland and MG

  • The thymus gland is significantly related to myasthenia gravis (MG).
  • Abnormalities include hyperplasia or thymomas.
  • These can trigger or maintain the production of autoantibodies.
  • Attack the acetylcholine receptors leading to muscle weakness.